Managing the commercialization activities of Biotech, Medical Device and AI/ML technologies at the Technion, including licensing technologies to established companies, establishment of Spinoffs, companies and technologies due diligence as well as technology development .

Neural Flow (Changed name to Optium AI), developed an AI-driven SaaS platform that optimizes the performance of bioreactors and fermentors. Using four different AI engines Optium's real-time platform is turning cellular agriculture (cultivated meat) production into a cost-effective, efficient, and predictable process.

* Business Development- Allocate, lead, and execute new revenue engines for the company, based on technology, innovation, and business collaborations. * Product & Technology- Leading, owing, and managing the development of new products and technologies to the market, from concept to sales.

AseptoRay developed a proprietary cold pasteurization platform based on light filtration technology.

Product Manager of Ultrasound-based aesthetic products at the Aesthetic Business Unit (ASBU).Being Products Champion within the origination. - Marketing Strategy- Owning the marketing strategy and implementation of the assigned product portfolio across the different organizational functions and regional entities.- Value Proposition – Creating the products’ key value proposition and messaging per key stakeholders throughout the conversion funnel, and developing sales and marketing, competitive and economic tools.- Global teams- Working closely with Lumenis' regional teams and partners and actively driving the relationship, and translation of global marketing strategy to regional strategy.- Go-to-Market Strategy- Development of global go-to-market strategies (segmentation, targeting, positioning, pricing) to drive market share and profitable growth.- Competitive analysis - Perform business intelligence, market & competitive analysis and translate them into actionable business goals.

Screening medical device, aesthetic, and Cleantech proposals for Naiot Venture Accelerator. Counseling and supporting Naiot Portfolio companies to maximize value within incubation period, in order to meet the market in a quick and efficient manner and enable sufficient capital securing.

ENT-Surgical develops surgical solutions for ear nose and throat (ENT) applications. Major achievements:• Sold to a private investor. • Investment from US based VC. • LOI with Integra Lifesciences Corp (NASDAQ: IART)• 510K approval- Converting an FDA requirement for powered, non-inferiority study (~120 patients) into a complementary, non-significant study (16 patients).